Immunoclin (Immunoclin) Operating Cash Flow per Share : $-0.01 (TTM As of Oct. 2014)

View and export this data going back to 2012. Start your Free Trial

What is Immunoclin Operating Cash Flow per Share?

Immunoclin's operating cash flow per share for the three months ended in Oct. 2014 was $0.01. Immunoclin's operating cash flow per share for the trailing twelve months (TTM) ended in Oct. 2014 was $-0.01.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Immunoclin's Operating Cash Flow per Share or its related term are showing as below:

IMCL's 3-Year OCF Growth Rate is not ranked ^*
in the Biotechnology industry.
Industry Median: 3.5
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

Immunoclin Operating Cash Flow per Share Historical Data

The historical data trend for Immunoclin's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunoclin Operating Cash Flow per Share Chart

Immunoclin Annual Data

Trend

Feb12

Jan13

Jan14

Operating Cash Flow per Share

-0.01

0.03

-0.01

Immunoclin Quarterly Data
	May11	Aug11	Nov11	Feb12	May12	Aug12	Nov12	Feb13	May13	Aug13	Nov13	Apr14	Jul14	Oct14
Operating Cash Flow per Share	Get a 7-Day Free Trial									-	-	-	-0.01	0.01

Competitive Comparison of Immunoclin's Operating Cash Flow per Share

For the Biotechnology subindustry, Immunoclin's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Immunoclin's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Immunoclin's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Immunoclin's Price-to-Operating-Cash-Flow falls into.

Immunoclin Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Immunoclin's Operating Cash Flow per Share for the fiscal year that ended in Jan. 2014 is calculated as

Operating Cash Flow per Share (A: Jan. 2014 )	=	Cash Flow from Operations (A: Jan. 2014 )	/	Shares Outstanding (Diluted Average) (A: Jan. 2014 )
	=	-0.111	/	10.775
	=	-0.01

Immunoclin's Operating Cash Flow per Share for the quarter that ended in Jan. 2014 is calculated as

Operating Cash Flow per Share (Q: Oct. 2014 )	=	Cash Flow from Operations (Q: Oct. 2014 )	/	Shares Outstanding (Diluted Average) (Q: Oct. 2014 )
	=	0.198	/	27.896
	=	0.01

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Oct. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.01

Immunoclin Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Immunoclin's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Immunoclin (Immunoclin) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunoclin Corp (GREY:IMCL) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

9107 Wilshire Boulevard, Suite 450, Beverly Hills, CA, USA, 90210

Website

http://www.immunoclin.com

Immunoclin Corp is engaged in immunology research and development skill to serve the pharmaceutical, biotechnology and food industries, providing comprehensive, clinical and basic science research expertise at a commercial scale and quality.

Immunoclin (Immunoclin) Headlines

No Headlines